Skip to main content

Table 1 Clinical characteristics of the study population

From: Prognostic implications of surrogate markers of atherosclerosis in low to intermediate risk patients with Type 2 Diabetes

Characteristic

All

With Atherosclerotic Event

Without Atherosclerotic Event

P-value

 

(N = 151)

(N = 17)

(N = 134)

 

Age, years

60.9 ± 10.0

64.9 ± 10.1

60.4 ± 9.9

0.079

Males, n (%)

61 (40)

10 (59)

51 (38)

0.10

Hypertension, n (%)

89 (60)

8 (47)

81 (62)

0.24

Hypercholesterolemia, n (%)

80 (56)

9 (60)

71 (55)

0.71

Ever-smokers, n (%)

27 (18)

6 (35)

21 (16)

0.047

Family history of CVD, n (%)

25 (17)

2 (12)

23 (17)

0.57

Duration of DM, years

15.2 ± 7.5

14.1 ± 7.8

15.3 ± 7.5

0.54

BMI, kg/m2

25.6 ± 4.1

23.8 ± 3.3

25.8 ± 4.1

0.061

WHR

88.5 ± 10.4

85.6 ± 8,5

88.9 ± 10.6

0.23

Systolic blood pressure, mmHg

140 ± 21

143 ± 21

139 ± 21

0.46

Diastolic blood pressure, mmHg

78 ± 9

76 ± 9

78 ± 9

0.49

Fasting blood glucose, mmol/L

7.5 ± 2.0

8.0 ± 2.9

7.5 ± 1.9

0.38

HbA1c, %

7.7 ± 1.2

7.7 ± 1.1

7.7 ± 1.3

0.94

Triglyceride, mmol/L

1.5 ± 1.2

1.5 ± 0.8

1.6 ± 1.2

0.77

Total cholesterol, mmol/L

4.9 ± 0.9

5.0 ± 1.1

4.9 ± 0.9

0.69

LDL-C, mmol/L

2.8 ± 0.8

3.0 ± 0.8

2.8 ± 0.7

0.46

HDL-C, mmol/L

1.4 ± 0.4

1.4 ± 0.3

1.4 ± 0.4

0.73

GFR, ml/min/1.73 m2

84 ± 22

74 ± 27

85 ± 21

0.059

Beta-blocker, n (%)

29 (21)

2 (13)

27 (22)

0.40

Calcium channel blocker, n (%)

50 (36)

4 (25)

46 (37)

0.35

ACEI/ARB, n (%)

44 (31)

6 (38)

38 (30)

0.56

Aspirin, n (%)

8 (6)

1 (6)

7 (6)

0.92

Statin, n (%)

30 (21)

5 (31)

25 (20)

0.31

Oral hypoglycemic agent, n (%)

115 (82)

13 (81)

102 (82)

0.92

Insulin, n (%)

24 (17)

2 (13)

22 (18)

0.60

Retinopathy, n (%)

23 (16)

3 (19)

20 (16)

0.76

Urine albumin g/l

0.07 ± 0.2

0.1 ± 0.3

0.1 ± 0.2

0.60

FRS, %

5.0 ± 4.6

5.9 ± 5.0

4.9 ± 4.5

0.41

FMD, %

2.8 ± 3.8

1.7 ± 3.9

2.9 ± 3.7

0.22

mmIMT, mm

0.9 ± 0.2

1.1 ± 0.3

0.9 ± 0.2

0.047

Carotid plaque, n (%)

85 (57)

12 (71)

73 (55)

0.22

ABI

1.1 ± 0.1

1.0 ± 0.2

1.1 ± 0.1

0.080

baPWV, cm/s

1752 ± 384

1897 ± 373

1732 ± 383

0.20

CACS

148 ± 353

374 ± 341

120 ± 346

0.011

  1. Abbreviations: ABI = ankle brachial index; ACEI = angiotensin converting enzyme inhibitor; ARB = angiotensin receptor blocker; baPWV = brachial-ankle pulse wave velocity; BMI = body mass index; CACS = coronary artery calcium score; CVD = cardiovascular disease; DM = diabetes mellitus; FMD = flow mediated dilatation; FRS = Framingham Risk Score; GFR = glomerular filtration rate; HbA1c = haemoglobin A1c; HDL = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; mmIMT = mean maximum intima-media thickness; WHR = waist-hip circumference ratio.